Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. announced that the FDA has approved Sezaby (phenobarbital sodium powder for injection) for the treatment of neonatal seizures.
Purpose: Levetiracetam is a broad-spectrum anti-epileptic drug that is effective against both focal and generalized epilepsies. In this study, we aimed to evaluate the efficacy, tolerability and safety of levetiracetam monotherapy in the management of different seizure types in children with epilepsy under the age of two.